Challenges
The client faced multiple regulatory hurdles, including limited internal knowledge of Canadian medical device regulations and the absence of formal Standard Operating Procedures. A key challenge was defining a precise Intended Use statement that would avoid an unnecessarily high risk classification, all while meeting an extremely compressed regulatory timeline.
Solutions
The team worked closely with the client to clearly define the Intended Use and align the product with a lower-risk regulatory pathway. Required SOPs were developed and implemented to meet Health Canada expectations, including complaint handling and post-market surveillance. Hands-on compliance training was also provided to prepare the team for ongoing regulatory responsibilities.
Results
-
Regulatory foundation established
-
Health Canada approval in days
-
Accelerated MDEL issuance
-
Early market entry achieved
-
First-mover advantage secured
Conclusion
This case demonstrates how focused regulatory strategy, combined with practical implementation and close collaboration, can enable rapid approval and early market access for low-risk digital health products.